CIZZLE BIOTECHNOLOGY HOLDINGS PLC
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
CIZ | IL
Overview
Corporate Details
- ISIN(s):
- GB00BNG2VN02
- LEI:
- 213800G3OS3SA2J1Y358
- Country:
- United Kingdom
- Address:
- 6TH FLOOR, 60 GRACECHURCH STREET, EC3V 0HR LONDON
- Website:
- https://cizzlebiotechnology.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cizzle Biotechnology Holdings PLC is a diagnostics company developing a non-invasive blood test for the early detection of lung cancer. The company's core product utilizes its proprietary CIZ1B biomarker, an advanced immunoassay designed to identify lung cancer at its earliest, most treatable stages with high sensitivity. This cost-effective solution aims to streamline the diagnostic pathway for healthcare providers, reducing reliance on CT scans and minimizing unnecessary invasive follow-up procedures. Originating as a spin-out from the University of York, Cizzle is advancing its technology through global clinical trials to secure regulatory approval and improve patient outcomes worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-05 08:35 |
Capital/Financing Update
£250,000 Convertible Loan Note Issue
|
English | 16.3 KB | ||
| 2025-11-05 08:20 |
Regulatory Filings
LOI with leading UK Clinical Diagnostic Group
|
English | 16.3 KB | ||
| 2025-09-29 08:00 |
Regulatory Filings
Update on Clinical Laboratory Partnerships in USA
|
English | 22.2 KB | ||
| 2025-08-18 08:00 |
Regulatory Filings
Commercial Progress in USA
|
English | 22.0 KB | ||
| 2025-07-08 10:40 |
Annual Report
Annual Report for the year ended 31 December 2024
|
English | 332.7 KB | ||
| 2025-06-06 12:00 |
Report Publication Announcement
Notice of AGM
|
English | 11.4 KB | ||
| 2025-05-28 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.1 KB | ||
| 2025-03-25 08:00 |
Board/Management Information
Appointment of Non-Executive Director
|
English | 15.7 KB | ||
| 2025-01-02 08:00 |
Board/Management Information
Appointment of Professor Dawn Coverley as CSO
|
English | 17.8 KB | ||
| 2024-12-16 08:00 |
M&A Activity
Update on Strategic Partnership in North America
|
English | 23.8 KB | ||
| 2024-10-21 08:00 |
M&A Activity
Execution of Agreement for North America
|
English | 25.9 KB | ||
| 2024-10-03 14:12 |
Regulatory Filings
Update on Licensing and Partnership Agreement
|
English | 10.6 KB | ||
| 2024-09-30 08:00 |
Interim / Quarterly Report
Interim Results
|
English | 208.3 KB | ||
| 2024-09-16 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 37.5 KB | ||
| 2024-09-09 08:00 |
Regulatory Filings
Collaboration with Moffitt Cancer Center
|
English | 25.0 KB |
Automate Your Workflow. Get a real-time feed of all CIZZLE BIOTECHNOLOGY HOLDINGS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CIZZLE BIOTECHNOLOGY HOLDINGS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CIZZLE BIOTECHNOLOGY HOLDINGS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
